Initial Therapeutics, Inc. seeks a senior individual contributor to advance molecular and genomic biomarker strategies at their Harwell site in the UK. The role offers significant independence in the development of advanced molecular assays, leading a diverse clinical portfolio.
Candidates should have a Ph.D. in Molecular Biology with over 9 years of experience and deep expertise in qPCR, dPCR, and NGS assays. The position emphasizes collaboration across teams to ensure alignment on clinical objectives while contributing to cutting-edge research.
Exceptional benefits include healthcare, paid time off, and professional development resources.
#J-18808-Ljbffr
Contact Details:
Initial Therapeutics, Inc. Recruitment Team
